Strength
320 mg/2mL
Manufacturer
UCB, Inc.NDC
50474078284
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
BIMEKIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761151On Market Since
12/5/2024
Price Statistics
The NADAC for BIMZELX 320 MG/2 ML AUTOINJECT has been published 28 times since Dec 17, 2025, and over the history we have for it it has risen 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8023.8367 per ML |
|---|---|
| All-time high | $8067.9674 (May 13, 2026) |
| All-time low | $7654.6180 (Dec 17, 2025) |
| 52-week high | $8067.9674 |
| 52-week low | $7654.6180 |
| Median price | $8067.9674 |
| Average price | $8000.5875 |
| Largest weekly change | +5.4% (Jan 14, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the bimekizumab market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BIMZELX 320 MG/2 ML AUTOINJECT?
The current National Average Drug Acquisition Cost (NADAC) for BIMZELX 320 MG/2 ML AUTOINJECT, manufactured by UCB, Inc., is $8023.8367 per ML (NDC 50474078284), effective Jun 24, 2026.
How has the price of BIMZELX 320 MG/2 ML AUTOINJECT changed over time?
Over the history we have for it, the NADAC for BIMZELX 320 MG/2 ML AUTOINJECT has risen 4.8%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for BIMZELX 320 MG/2 ML AUTOINJECT?
Since Dec 17, 2025, the NADAC for BIMZELX 320 MG/2 ML AUTOINJECT has ranged from a low of $7654.6180 (Dec 17, 2025) to a high of $8067.9674 (May 13, 2026), with a median of $8067.9674 per ML.
Are there cheaper alternatives to BIMZELX 320 MG/2 ML AUTOINJECT?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BIMZELX 320 MG/2 ML AUTOINJECT, so no direct lower-cost alternative is listed.
Who manufactures BIMZELX 320 MG/2 ML AUTOINJECT?
BIMZELX 320 MG/2 ML AUTOINJECT (NDC 50474078284) is labeled by UCB, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification